Glynase and Cardiac failure - a phase IV clinical study of FDA data

Summary:

Cardiac failure is reported as a side effect among people who take Glynase (glyburide), especially for people who are male, 60+ old, also take Actos, and have Arrhythmias.

The phase IV clinical study analyzes which people have Cardiac failure when taking Glynase. It is created by eHealthMe based on reports of 1,511 people who have side effects when taking Glynase from the FDA, and is updated regularly.

What is Glynase?

Glynase has active ingredients of glyburide. eHealthMe is studying from 1,513 Glynase users. Check the latest studies of Glynase.

What is Cardiac failure?

Cardiac failure is found to be associated with 2,060 drugs and 2,213 conditions by eHealthMe. Check the latest studies of Cardiac failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,511 people reported to have side effects when taking Glynase.
Among them, 37 people (2.45%) have Cardiac failure.

Among these 37 people:

What is the gender of people who have Cardiac failure when taking Glynase? *

female: 48.65 %
male: 51.35 %

What is the age of people who have Cardiac failure when taking Glynase? *

What are other drugs people take besides Glynase? *

What are other side effects people have besides Cardiac failure? *

Weight Increased: 9 people, 24.32%
Oedema Lower Limb (fluid collection in tissue of lower leg): 9 people, 24.32%
Pleural Effusion (water on the lungs): 8 people, 21.62%
Cough: 6 people, 16.22%
Respiratory Distress (difficulty in breathing): 5 people, 13.51%
Pulmonary Congestion (congestion in the lungs): 5 people, 13.51%
Weakness: 5 people, 13.51%
Fever: 4 people, 10.81%
Heart Rate Decreased: 4 people, 10.81%
Urination - Painful: 4 people, 10.81%

What are the existing conditions these people have? *

Arrhythmias (irregular heartbeat): 2 people, 5.41%
Pain: 1 person, 2.70%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.70%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Glynase and have Cardiac failure?

- Check whether Cardiac failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glynase:

Glynase (1,513 reports)

Cardiac failure treatments and more:

Cardiac failure (147,157 reports)

Browse all side effects of Glynase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure:

Cardiac failure (2,060 drugs)

Browse all the conditions that are associated with Cardiac failure:

Cardiac failure (2,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Glynase) and Glynase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.